MedTrace Logo

Gastrointestinal Tolerance of Infant Formula

NCT02322138 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2015-07-23

No results posted yet for this study

Summary

The study objective is to evaluate the gastrointestinal tolerance of infant formula supplemented with prebiotics.

Conditions

  • Gastrointestinal Tolerance

Interventions

OTHER

Experimental 1 Infant Formula

Ready to feed infant formula to be fed ad-libitum

OTHER

Experimental 2 Infant Formula

Ready to feed infant formula to be fed ad-libitum

OTHER

Reference Group

Breast fed ad libitum

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Janice Kajzer, MS, RD, LD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
8 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322138 on ClinicalTrials.gov